Brain scans reveal how stuttering works in new drug study
NCT ID NCT07215884
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study gives aripiprazole, a drug that affects dopamine, to 40 adults who stutter to see how it changes brain activity during speech. Researchers use brain scans and audio recordings to measure how the brain processes sound before and during speaking. The goal is to better understand the brain pathways involved in stuttering, not to test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STUTTERING, ADULT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Biomagentic Imaging Lab
RECRUITINGSan Francisco, California, 94143, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a once-daily pill ease stuttering? a trial puts lumateperone to the test.
- Brain scans and speech tasks aim to unlock the secrets of stuttering
- Can an app help people who stutter speak more fluently?
- Brain zaps show promise for stuttering relief
- Brain zaps for stuttering? tiny trial tests rTMS
- Brain zaps may unlock fluency for people who stutter